AGER and diabetes mellitus: Our previous study showed that GA prevents diabetes-induced renal lesion and inflammatory responses by suppressing receptor for advanced glycation end products (RAGE)/Toll-like receptor 4-related ERK and p38 mitogen-activated protein kinases (p38MAPK)/NF-κBp65 activation[23].